In the context of PPARγ gene polymorphisms, Paynter et al. genotyped the PPARγ Pro12Ala polymorphism in a cohort of invasive endometrial cancer cases and concluded that the aforementioned polymorphism did not seem to mediate circulating estrogen levels or endometrial cancer susceptibility [32]. The gene discussed is PPARG; the disease is endometrial cancer.